DSDavid D. Spragg

David D. Spragg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David D. Spragg has a total of 150 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Relationships between three-dimensional fibrosis distribution, atrial adiposity, and voltage abnormalities associated with persistent atrial fibrillation

    by Kensuke Sakata, Adityo Prakosa, Carolyna A P Yamamoto, Syed Yusuf Ali, Yazan Mohsen, Shane Loeffler, Eugene G Kholmovski, Joseph E Marine, Hugh Calkins, David D Spragg, et al.

    Persistent atrial fibrillation (PsAF) is often refractory to pulmonary vein isolation, a well-established AF treatment, owing to the fibrosis-remodeled substrates sustaining reentries. Three-dimensional fibrosis distribution and atrial adiposity have been found to be essential contributors to PsAF arrhythmogenesis. We aimed to utilize late gadolinium enhancement (LGE)-MRI-derived personalized heart digital twins (DTs)—a recent promising tool for non-invasively assessing patient arrhythmogenesis—as well as contrast-enhanced cardiac computed tomography (CCT) images and electroanatomic maps (EAMs) to investigate relationships between fibrosis distribution, including endo–epi differences, adiposity infiltration, and electrophysiological abnormalities, and their influence on PsAF arrhythmogenic substrate. DTs incorporating fibrosis distribution were generated from consecutive PsAF patients’ LGE-MRIs. Using rapid pacing, potential locations attracting reentries (LRs) were identified in DTs. CCTs were used to segment adipose tissue within pericardial sac and evaluate the distance from endocardial surface to closest adipose tissue (DEnCA). Bipolar- and unipolar-low-voltage area fractions (LVFs) were extracted from EAMs. Volumetric fibrosis fraction (FF) and surface FF on endocardial and epicardial surfaces at LRs and non-LRs were analyzed in relation to DEnCA and LVF. In 22 patients, adipose tissue volume correlated with BMI and CHA2DS2-VASc and, together with atrial-FF, predicted number of LRs. At LRs and non-LRs, while volumetric-FF was the sole determinant of LR classification, volumetric-FF correlated with endocardium-predominant fibrosis and bipolar-LVF. Endocardium-predominant fibrosis was independently linked to DEnCA. This study highlights the complex interactions between structural features, such as three-dimensional fibrosis distribution and atrial adiposity infiltration, electrophysiological features, and PsAF arrhythmogenesis.


  • Beyond Recurrence

    by Nino Isakadze, David D. Spragg

  • Trends of single-center complication rates for catheter ablation of atrial fibrillation from 2015 to 2024

    by Robert M. Weinstein, Danish Lltaf Satti, Tina Reddy, David Hutto, Alex Karius, Ritu Yadav, Nino Isakadze, Jenna Milstein, Konstantinos N. Aronis, Joseph E. Marine, et al.


  • Social Determinants of Health and Disparities in Diagnosis-to-Ablation Time for Atrial Fibrillation

    by Danish Iltaf Satti, Jeffrey Shi Kai Chan, Robert Weinstein, Julia De Conti Pelanda, Hassan Mirbolouk, Linh Tran, Jenna Milstein, Keva Garg, Elham Hatef, Nino Isakadze, et al.


  • Effects of Glucagon-Like Peptide-1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation

    by Danish Iltaf Satti, Alexander Karius, Jeffrey Shi Kai Chan, Nino Isakadze, Ritu Yadav, Keva Garg, Konstantinos N. Aronis, Joseph E. Marine, Ronald Berger, Hugh Calkins, et al.


  • Pericarditis After Catheter Ablation for Atrial Fibrillation

    by Ritu Yadav, Danish Iltaf Satti, Jui Malwankar, Carolina Lopez-Silva, Lillian Xu, Elana Liebow-Feeser, Tauseef Akhtar, Joseph E. Marine, Ronald Berger, Hugh Calkins, et al.


  • Sex‐based differences in safety and efficacy of catheter ablation for atrial fibrillation

    by Ritu Yadav, Jenna Milstein, Jacob Blum, Stefany Lazieh, Victor Yang, Xiyu Zhao, Siam Muquit, Jui Malwankar, Joseph E. Marine, Ronald Berger, et al.

    Background: Studies have identified significant sex‐based differences and disparities in the clinical presentation and treatment of atrial fibrillation (AF). Studies have shown women are less likely to be referred for catheter ablation, are older at the time of ablation, and are more likely to have recurrence after ablation. However, in most studies investigating AF ablation outcomes, the female cohorts were relatively small. The impact of sex on the outcome and safety of ablation procedures is still unclear.Objective: To investigate sex‐based differences in outcomes and complications after AF catheter ablation, with a significant female cohortMethod: In this retrospective study, patients undergoing AF ablation from January 1, 2014, to March 31, 2021, were included. We investigated clinical characteristics, duration and progression of AF, number of EP appointments from diagnosis to ablation, procedural data, and procedure complications.Results: Total of 1346 patients underwent first catheter ablation for AF during this period, including 896 (66.5%) male and 450 (33.4%) female patients. Female patients were older at the time of ablation (66.2 vs. 62.4 years; p < .001). Women had higher CHA2DS2‐VASc (congestive heart failure, hypertension, age, diabetes, stroke, vascular disease, sex category) scores (3 vs. 2; p < .001) than men, expectedly, as the female sex warrants an additional point. 25.3% female patients had PersAF at the time of diagnosis versus 35.3% male patients (p < .001). At the time of ablation, 31.8% female patients had PersAF as compared to 43.1% male patients (p < .001), indicating progression of PAF to PersAF in both sexes. Women tried more AADs than men before ablation (1.13 vs. 0.98; p = .002). Male and female patients had no statistically significant difference in (a) arrhythmia recurrence at 1‐year post ablation (27.7% vs. 30%; p = .38) or (b) procedural complication rate (1.8% vs. 3.1%; p = .56).Conclusion: Female patients were older and had higher CHA2DS2‐VASc scores compared to males at the time of AF ablation. Women tried more AADs than men before ablation. One‐year arrhythmia recurrence rates and procedural complications were similar in both sexes. No sex‐based differences were observed in safety and efficacy of ablation.


  • Open Access

    Sex- Based Differences in Safety and Efficacy of Catheter Ablation for Atrial Fibrillation

    by Ritu Yadav, Jenna Milstein, Jacob Blum, Stefany Lazieh, Victor Yang, Xiyu Zhao, Siam Muquit, Jui Malwankar, Joseph Marine, Ronald Berger, et al.

    Background: Studies have identified significant sex-based differences and disparities in the clinical presentation and treatment of atrial fibrillation (AF). Studies have shown women are less likely to be referred for catheter ablation, are older at the time of ablation, and are more likely to have recurrence after ablation. However, in most studies investigating AF ablation outcomes, the female cohorts were relatively small. The impact of gender on the outcome and safety of ablation procedures is still unclear. Objective: To investigate sex-based differences in outcomes and complications after AF catheter ablation, with a significant size female cohort Method: In this retrospective study, patients undergoing AF ablation from January 1, 2014, to March 31, 2021, were included. We investigated clinical characteristics, duration and progression of AF, number of EP appointments from diagnosis to ablation, procedural data, and procedure complications. Results: Total 1346 patients underwent first catheter ablation for AF during this period, including 896 (66.5%) male and 450 (33.4%) female patients. Female patients were older at the time of ablation (66.2y vs 62.4y; p2 DS 2 -VASc scores (3 vs 2; pConclusion: Female patients were older and had higher CHA 2 DS 2 -VASc scores compared to males at the time of AF ablation. Women tried more AADs than men prior to ablation. 1-y arrhythmia recurrence rates and procedural complications were similar in both genders. No sex- based differences were observed in safety and efficacy of ablation.